Back to Search
Start Over
Effect of dietary pulse intake on established therapeutic lipid targets for cardiovascular risk reduction: a systematic review and meta-analysis of randomized controlled trials
- Source :
- CMAJ: Canadian Medical Association Journal. May 13, 2014, Vol. 186 Issue 8, , E252, p11 p.
- Publication Year :
- 2014
-
Abstract
- Background: Evidence from controlled trials encourages the intake of dietary pulses (beans, chickpeas, lentils and peas) as a method of improving dyslipidemia, but heart health guidelines have stopped short of ascribing specific benefits to this type of intervention or have graded the beneficial evidence as low. We conducted a systematic review and meta-analysis of randomized controlled trials (RCTs) to assess the effect of dietary pulse intake on established therapeutic lipid targets for cardiovascular risk reduction. Methods: We searched electronic databases and bibliographies of selected trials for relevant articles published through Feb. 5, 2014. We included RCTs of at least 3 weeks' duration that compared a diet emphasizing dietary pulse intake with an isocaloric diet that did not include dietary pulses. The lipid targets investigated were low-density lipopro tein (LDL) cholesterol, apolipoprotein B and non-high-density lipoprotein (non-HDL) cholesterol. We pooled data using a randomeffects model. Results: We identified 26 RCTs (n = 1037) that satisfied the inclusion criteria. Diets emphasizing dietary pulse intake at a median dose of 130 g/d (about 1 serving daily) significantly lowered LDL cholesterol levels compared with the control diets (mean difference -0.17mmol/L, 95% confidence interval -0.25 to -0.09 mmol/L). Treatment effects on apolipoprotein B and non-HDL cholesterol were not observed. Interpretation: Our findings suggest that dietary pulse intake significantly reduces LDL cholesterol levels. Trials of longer duration and higher quality are needed to verify these results. Trial registration: ClinicalTrials.gov, no. NCT01594567.<br />Abnormal blood concentrations of lipids are one of the most important modifiable risk factors for cardiovascular disease. Although statins are effective in reducing low-density lipoprotein (LDL) cholesterol levels, major health [...]
- Subjects :
- Coca-Cola Co. (Atlanta, Georgia)
Abbott Laboratories (Abbott Park, Illinois)
Canada. Canadian Institutes of Health Research
Calorie Control Council
Canadian Diabetes Association
World Health Organization
Blood cholesterol -- Health aspects
Soft drink industry -- Health aspects
Trans fatty acids -- Health aspects
Cardiovascular diseases -- Risk factors -- Health aspects
Low density lipoproteins -- Health aspects
Pharmaceutical industry -- Health aspects
Health
Risk factors
Health aspects
Subjects
Details
- Language :
- English
- ISSN :
- 08203946
- Volume :
- 186
- Issue :
- 8
- Database :
- Gale General OneFile
- Journal :
- CMAJ: Canadian Medical Association Journal
- Publication Type :
- Periodical
- Accession number :
- edsgcl.368075286
- Full Text :
- https://doi.org/10.1503/cmaj.131727